Cover Image
市場調查報告書

血栓消除設備市場:各設備技術(機械性,抽吸式,水流沖吸式),設備類別(自動,手動),利用性別(再利用,拋棄式),及各疾病-全球機會分析與產業預測

Thrombectomy Devices Market by Thrombectomy Devices Technology (Mechanical, Aspiration, Rheolytic), Devices Type (Automated, Manual), Utility (Reusable Disposable Devices) and Diseases - Opportunity Analysis and Industry Forecast, 2014 - 2022

出版商 Allied Market Research 商品編碼 374538
出版日期 內容資訊 英文 118 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
血栓消除設備市場:各設備技術(機械性,抽吸式,水流沖吸式),設備類別(自動,手動),利用性別(再利用,拋棄式),及各疾病-全球機會分析與產業預測 Thrombectomy Devices Market by Thrombectomy Devices Technology (Mechanical, Aspiration, Rheolytic), Devices Type (Automated, Manual), Utility (Reusable Disposable Devices) and Diseases - Opportunity Analysis and Industry Forecast, 2014 - 2022
出版日期: 2016年09月01日 內容資訊: 英文 118 Pages
簡介

本報告提供全球血栓消除設備市場相關調查,彙整市場概要與預測,競爭趨勢,及加入此市場的主要企業簡介等資料。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 波特五力分析
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會

第4章 全球血栓消除設備市場:各技術

  • 概要
  • 機械性血栓消除設備
  • 吸引型血栓消除設備
  • 水流沖吸式血栓消除設備

第5章 全球血栓消除設備市場:各類型

  • 概要
  • 自動設備
  • 手動設備

第6章 全球血栓消除設備市場:利用性別

  • 概要
  • 再利用
  • 拋棄式

第7章 全球血栓消除設備市場:各疾病

  • 概要
  • 末梢疾病
  • 冠狀動脈疾病
  • 神經疾病

第8章 全球血栓消除設備市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美

第9章 企業簡介

  • Boston Scientific Corporation
  • Medtronic Plc
  • Teleflex Incorporated
  • Terumo Corporation
  • Penumbra, Inc.
  • The Spectranetics Corporation
  • AngioDynamics, Inc.
  • Vascular Solutions, Inc.
  • Johnson & Johnson, Inc.
  • Stryker Corporation

圖表

目錄
Product Code: LI 161608

Thrombectomy is the surgical removal of blood clot from a blood vessel. Venous thromboembolism (VTE) is a common lethal disease where blood clots within a vein. These clots can travel to arteries or veins in different parts of the body-brain, heart, kidneys, lungs, and limbs. VTE is considered as the cause of heart attack, stroke; however, it can also damage to the body's organs or even death. VTE results due to various factors, which include combination of hereditary and acquired risk factors, obesity and post-surgery especially hip, knee, or pelvic surgery. It can be found in smoking population and people who take estrogens or birth control pills. VTE is most common in adults (>60 years) but can occur at any age.

The world thrombectomy devices market is estimated to garner $1,389 million by 2022. This is attributed by the increase in the incidence of acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, and pulmonary embolism due to the sedentary lifestyle, and unhealthy living conditions and habits in the current generation; rise in the geriatric population. The increase in incidence of cardiovascular diseases; growth in demand for minimally-invasive procedures, and demand for better healthcare infrastructure; and increase in competition, has led to technological advancements and innovations. However, lack of trained professionals and awareness, and complicated use of these devices restrict the market growth. In addition, deep vein thrombosis and pulmonary embolism sometimes remain underdiagnosed and can lead to serious health conditions, which can only be avoided by avoiding sedentary lifestyle and creating awareness among all.

The world thrombectomy devices market is segmented into five categories-technology, type, utility, disease, and geography. Based on the type of technology, the market is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, rheolytic thrombectomy devices. Based on type, the market is divided into automated devices and manual devices. Based on utility, the market is classified into reusable devices and disposable devices. The thrombectomy devices market is segmented into three disease categories, which include peripheral diseases, coronary diseases, and neuro diseases. Based on geography, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.

The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players in the thrombectomy devices market. On September 2015, Medtronic acquired Lazarus Effect to strengthen its market of clot removal devices effective during ischemic stroke. Boston Scientific completed the acquisition of interventional business of Bayer AG on May 2014. This made Boston Scientific the leading innovator for peripheral vascular disease in the industry, and expanded their product portfolio and sales force across various geographies.

KEY MARKET BENEFITS:

  • The quantitative analysis of the current trends and future estimations from 2014 to 2022 is provided to identify the prevailing opportunities and formulate growth strategies.
  • In-depth analysis of the market based on geography gives an understanding of the regional market, which assists in strategic business planning.
  • A detailed analysis based on technology is presented to understand the type of products in trend or would be in demand to assist in product developments and collaborations.
  • Comprehensive analysis of the market drivers and constraints is provided to identify the prevailing market opportunities.
  • Competitive intelligence highlights the business practices followed by leading market players across various geographies.

KEY MARKET SEGMENTS:

The world thrombectomy devices market segmentation is illustrated as follows:

BY TECHNOLOGY

  • Mechanical Thrombectomy Devices
  • Aspiration Thrombectomy Devices
  • Rheolytic Thrombectomy Devices

BY TYPE

  • Automated Devices
  • Manual Devices

BY UTILITY

  • Reusable Devices
  • Disposable Devices

BY DISEASES

  • Peripheral Diseases
  • Coronary Diseases
  • Neural Diseases

BY GEOGRAPHY

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Others
  • Asia-Pacific
    • China
    • Japan
    • India
    • Others
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Others

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits
  • 1.3. Key market segments
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top investment pockets
    • 3.2.2. Top winning strategies
  • 3.3. Porters five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Moderate bargaining power of buyers
    • 3.3.3. Moderate threat of new entrants
    • 3.3.4. Moderate threat of substitutes
    • 3.3.5. High competitive rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. High prevalence of PAD, AMI, DVT & PE conditions
      • 3.4.1.2. Rise in geriatric population
      • 3.4.1.3. Growing demand of minimally invasive procedures
      • 3.4.1.4. Better healthcare infrastructure
      • 3.4.1.5. High competiton among key players
    • 3.4.2. Restraints
      • 3.4.2.1. Lack of trained professionals and awareness
      • 3.4.2.2. High cost and complicated use of thrombectomy devices
    • 3.4.3. Opportunities
      • 3.4.3.1. Introductin of lasers and uv radiation, and 3D imaging generation in thrombectomy devices
      • 3.4.3.2. Combination of decompressive surgery and thrombectomy

CHAPTER 4: WORLD THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 2014-2022

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Mechanical thrombectomy devices
    • 4.2.1. Key market trends
    • 4.2.2. Key growth factors and opportunities
    • 4.2.3. Market size and forecast
  • 4.3. Aspiration thrombectomy devices
    • 4.3.1. Key market trends
    • 4.3.2. Key growth factors and opportunities
    • 4.3.3. Market size and forecast
  • 4.4. Rheolytic thrombectomy devices
    • 4.4.1. Key market trends
    • 4.4.2. Key growth factors and opportunities
    • 4.4.3. Market size and forecast

CHAPTER 5: WORLD THROMBECTOMY DEVICES MARKET, BY TYPE, 2014-2022

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Automated devices
    • 5.2.1. Key market trends
    • 5.2.2. Key growth factors and opportunities
    • 5.2.3. Market size and forecast
  • 5.3. Manual devices
    • 5.3.1. Key market trends
    • 5.3.2. Key growth factors and opportunities
    • 5.3.3. Market size and forecast

CHAPTER 6: WORLD THROMBECTOMY DEVICES MARKET, BY UTILITY, 2014-2022

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Reusable devices
    • 6.2.1. Key market trends
    • 6.2.2. Key growth factors and opportunities
    • 6.2.3. Market size and forecast
  • 6.3. Disposable devices
    • 6.3.1. Key market trends
    • 6.3.2. Key growth factors and opportunities
    • 6.3.3. Market size and forecast

CHAPTER 7: WORLD THROMBECTOMY DEVICES MARKET, BY DISEASES, 2014-2022

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Peripheral Diseases
    • 7.2.1. Key market trends
    • 7.2.2. Key growth factors and opportunities
    • 7.2.3. Market size and forecast
  • 7.3. Coronary Diseases
    • 7.3.1. Key market trends
    • 7.3.2. Key growth factors and opportunities
    • 7.3.3. Market size and forecast
  • 7.4. Neural Diseases
    • 7.4.1. Key market trends
    • 7.4.2. Key growth factors and opportunities
    • 7.4.3. Market size and forecast

CHAPTER 8: WORLD THROMBECTOMY DEVICES MARKET, BY GEOGRAPHY, 2014-2022

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. North America
    • 8.2.1. Key market trends
    • 8.2.2. Key growth factors and opportunities
    • 8.2.3. Market size and forecast
      • 8.2.3.1. U.S. Market size and forecast
      • 8.2.3.2. Canada Market size and forecast
      • 8.2.3.3. Mexcio Market size and forecast
  • 8.3. Europe
    • 8.3.1. Key market trends
    • 8.3.2. Key growth factors and opportunities
    • 8.3.3. Market size and forecast
      • 8.3.3.1. Germany Market Size And Forecast
      • 8.3.3.2. France Market Size And Forecast
      • 8.3.3.3. U.K. Market Size And Forecast
      • 8.3.3.4. Italy Market Size And Forecast
      • 8.3.3.5. Spain Market Size And Forecast
      • 8.3.3.6. Rest Of Europe Market Size And Forecast
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends
    • 8.4.2. Key growth factors and opportunities
    • 8.4.3. Market size and forecast
      • 8.4.3.1. Japan Market size and forecast
      • 8.4.3.2. China Market size and forecast
      • 8.4.3.3. India Market size and forecast
      • 8.4.3.4. Rest of Asia-Pacific Market size and forecast
  • 8.5. Latin America, Middle East, Africa (LAMEA)
    • 8.5.1. Key market trends
    • 8.5.2. Key growth factors and opportunities
    • 8.5.3. Market size and forecast
      • 8.5.3.1. Brazil Market size and forecast
      • 8.5.3.2. Saudi Arabia Market size and forecast
      • 8.5.3.3. South Africa Market size and forecast
      • 8.5.3.4. Rest of lamea Market size and forecast

CHAPTER 9: COMPANY PROFILES

  • 9.1. Boston Scientific Corporation
    • 9.1.1. Company overview
    • 9.1.2. Company snapshot
    • 9.1.3. Operating business segments
    • 9.1.4. Business performance
    • 9.1.5. Key strategic moves & developments
  • 9.2. Medtronic Plc
    • 9.2.1. Company overview
    • 9.2.2. Company snapshot
    • 9.2.3. Operating business segments
    • 9.2.4. Business performance
    • 9.2.5. Key strategic moves & developments
  • 9.3. Teleflex Incorporated
    • 9.3.1. Company overview
    • 9.3.2. Company snapshot
    • 9.3.3. Operating business segments
    • 9.3.4. Business performance
    • 9.3.5. Key strategic moves & developments
  • 9.4. Terumo Corporation
    • 9.4.1. Company overview
    • 9.4.2. Company snapshot
    • 9.4.3. Operating business segments
    • 9.4.4. Business performance
    • 9.4.5. Key strategic moves & developments
  • 9.5. Penumbra, Inc.
    • 9.5.1. Company overview
    • 9.5.2. Company snapshot
    • 9.5.3. Operating business segments
    • 9.5.4. Business performance
    • 9.5.5. Key strategic moves & developments
  • 9.6. The Spectranetics Corporation
    • 9.6.1. Company overview
    • 9.6.2. Company snapshot
    • 9.6.3. Operating business segments
    • 9.6.4. Business performance
    • 9.6.5. Key strategic moves & developments
  • 9.7. AngioDynamics, Inc.
    • 9.7.1. Company overview
    • 9.7.2. Company snapshot
    • 9.7.3. Operating business segments
    • 9.7.4. Business performance
    • 9.7.5. Key strategic moves & developments
  • 9.8. Vascular Solutions, Inc.
    • 9.8.1. Company overview
    • 9.8.2. Company snapshot
    • 9.8.3. Operating business segments
    • 9.8.4. Business performance
    • 9.8.5. Key strategic moves & developments
  • 9.9. Johnson & Johnson, Inc.
    • 9.9.1. Company overview
    • 9.9.2. Company snapshot
    • 9.9.3. Operating business segments
    • 9.9.4. Business performance
    • 9.9.5. Key strategic moves & developments
  • 9.10. Stryker Corporation
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Operating business segments
    • 9.10.4. Business performance
    • 9.10.5. Key strategic moves & developments

LIST OF TABLES

  • TABLE 1: WORLD THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
  • TABLE 2: WORLD MECHANICAL THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
  • TABLE 3: WORLD ASPIRATION THROMBECTOMY MARKET, BY REGION, 20142022 ($MILLION)
  • TABLE 4: WORLD RHEOLYTIC THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
  • TABLE 5: WORLD THROMBECTOMY DEVICES MARKET, BY TYPE, 2014 2022 ($MILLION)
  • TABLE 6: WORLD AUTOMATED THROMBECTOMY DEVICES MARKET, BY REGION, 2014 2022 ($MILLION)
  • TABLE 7: WORLD MANUAL THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
  • TABLE 8: WORLD THROMBECTOMY DEVICES MARKET, BY UTILITY, 20142022 ($MILLION)
  • TABLE 9: WORLD REUSABLE THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
  • TABLE 10: WORLD DISPOSABLE THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
  • TABLE 11: WORLD THROMBECTOMY DEVICES MARKET, BY DISEASES, 20142022 ($MILLION)
  • TABLE 12: WORLD THROMBECTOMY DEVICES MARKET FOR PERIPHERAL DISEASES, BY REGION, 20142022 ($MILLION)
  • TABLE 13: WORLD THROMBECTOMY DEVICES MARKET FOR CORONARY DISEASES, BY REGION, 20142022 ($MILLION)
  • TABLE 14: WORLD THROMBECTOMY DEVICES MARKET FOR NEURAL DISEASES, BY REGION, 20142022 ($MILLION)
  • TABLE 15: WORLD THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
  • TABLE 16: NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
  • TABLE 17: NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY TECHNOLGY, 20142022 ($MILLION)
  • TABLE 18: NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 19: NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY UTILITY, 20142022 ($MILLION)
  • TABLE 20: NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY DISEASES, 20142022 ($MILLION)
  • TABLE 21: EUROPE THROMBECTOMY DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
  • TABLE 22: EUROPE THROMBECTOMY DEVICES MARKET, BY TECHNOLGY, 20142022 ($MILLION)
  • TABLE 23: EUROPE THROMBECTOMY DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 24: EUROPE THROMBECTOMY DEVICES MARKET, BY UTILITY, 20142022 ($MILLION)
  • TABLE 25: EUROPE THROMBECTOMY DEVICES MARKET, BY DISEASES, 20142022 ($MILLION)
  • TABLE 26: ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
  • TABLE 27: ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY TECHNOLGY, 20142022 ($MILLION)
  • TABLE 28: ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 29: ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY UTILITY, 20142022 ($MILLION)
  • TABLE 30: ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY DISEASES, 20142022 ($MILLION)
  • TABLE 31: LAMEA THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
  • TABLE 32: LAMEA THROMBECTOMY DEVICES MARKET, BY TECHNOLGY, 20142022 ($MILLION)
  • TABLE 33: LAMEA THROMBECTOMY DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 34: LAMEA THROMBECTOMY DEVICES MARKET, BY UTILITY, 20142022 ($MILLION)
  • TABLE 35: LAMEA THROMBECTOMY DEVICES MARKET, BY DISEASES, 20142022 ($MILLION)
  • TABLE 36: BOSTON - COMPANY SNAPSHOT
  • TABLE 37: BOSTON OPERATING SEGMENTS
  • TABLE 38: MEDTRONIC - COMPANY SNAPSHOT
  • TABLE 39: MEDTRONIC OPERATING SEGMENTS
  • TABLE 40: TELEFLEX - COMPANY SNAPSHOT
  • TABLE 41: TELEFLEX - OPERATING SEGMENTS
  • TABLE 42: TERUMO - COMPANY SNAPSHOT
  • TABLE 43: TERUMO - OPERATING SEGMENTS
  • TABLE 44: PENUMBRA - COMPANY SNAPSHOT
  • TABLE 45: PENUMBRA - OPERATING SEGMENTS
  • TABLE 46: SPECTRANETICS - COMPANY SNAPSHOT
  • TABLE 47: SPECTRANETICS - OPERATING SEGMENTS
  • TABLE 48: ANGIODYNAMICS - COMPANY SNAPSHOT
  • TABLE 49: ANGIODYNAMICS - OPERATING SEGMENTS
  • TABLE 50: VASC. SOL. - COMPANY SNAPSHOT
  • TABLE 51: VASCULAR SOLUTIONS - OPERATING SEGMENTS
  • TABLE 52: J&J - COMPANY SNAPSHOT
  • TABLE 53: J&J - OPERATING SEGMENTS
  • TABLE 54: STRYKER - COMPANY SNAPSHOT
  • TABLE 55: STRYKER - OPERATING SEGMENTS

LIST OF FIGURES

  • FIG. 1: WORLD THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 2015 VS 2022, ($MILLION)
  • FIG. 2: WORLD MORTALITY RATE (PER 100,000 POPULATION), 2000 VS 2012
  • FIG. 3: TOP INVESTMENT POCKETS IN WORLD THROMBECTOMY DEVICES MARKET
  • FIG. 4: TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2012 2016)
  • FIG. 5: TOP WINNING STRATEGIES: TYPE
  • FIG. 6: PORTERS FIVE FORCES ANALYSIS
  • FIG. 7: TOP IMPACTING FACTORS
  • FIG. 8: PREVALENCE OF PERIPHERAL ARTERIAL DISEASE (PAD) BY AGE
  • FIG. 9: U.S. THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 10: CANADA THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 11: MEXCIO THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 12: GERMANY THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 13: FRANCE THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 14: U.K. THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 15: ITALY THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 16: SPAIN THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 17: OTHERS THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 18: JAPAN THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 19: CHINA THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 20: INDIA THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 21: OTHERS THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 22: BRAZIL THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 23: SAUDI ARABIA THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 24: SOUTH AFRICA THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 25: OTHERS THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
  • FIG. 26: BOSTON: REVENUE BY YEAR ($MILLION)
  • FIG. 27: BOSTON: REVENUE BY SEGMENT, 2015 (%)
  • FIG. 28: BOSTON: REVENUE BY GEOGRAPHY, 2015 (%)
  • FIG. 29: MEDTRONIC: REVENUE BY YEAR ($MILLION)
  • FIG. 30: MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)
  • FIG. 31: MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
  • FIG. 32: TELEFLEX: REVENUE BY YEAR ($MILLION)
  • FIG. 33: TELEFLEX: REVENUE BY SEGMENT, 2015 (%)
  • FIG. 34: TERUMO: REVENUE BY YEAR ($MILLION)
  • FIG. 35: TERUMO: REVENUE BY SEGMENT, 2015 (%)
  • FIG. 36: TERUMO: REVENUE BY GEOGRAPHY, 2015 (%)
  • FIG. 37: PENUMBRA: REVENUE BY YEAR ($MILLION)
  • FIG. 38: PENUMBRA: REVENUE BY SEGMENT, 2015 (%)
  • FIG. 39: PENUMBRA: REVENUE BY GEOGRAPHY, 2015 (%)
  • FIG. 40: SPECTRANETICS: REVENUE BY YEAR ($MILLION)
  • FIG. 41: SPECTRANETICS: REVENUE BY SEGMENT, 2015 (%)
  • FIG. 42: SPECTRANETICS: REVENUE BY GEOGRAPHY, 2015 (%)
  • FIG. 43: ANGIODYNAMICS: REVENUE BY YEAR ($MILLION)
  • FIG. 44: ANGIODYNAMICS: REVENUE BY SEGMENTS, 2016 (%)
  • FIG. 45: ANGIODYNAMICS: REVENUE BY GEOGRAPHY, 2016 (%)
  • FIG. 46: VASCULAR SOLUTIONS: REVENUE BY YEAR ($MILLION)
  • FIG. 47: VASCULAR SOLUTIONS: REVENUE BY SEGMENT, 2015 (%)
  • FIG. 48: VASCULAR SOLUTIONS: REVENUE BY GEOGRAPHY, 2015 (%)
  • FIG. 49: J&J: REVENUE BY YEAR ($MILLION)
  • FIG. 50: J&J: REVENUE BY SEGMENT, 2015 (%)
  • FIG. 51: J&J: REVENUE BY GEOGRAPHY, 2015 (%)
  • FIG. 52: STRYKER: REVENUE BY YEAR ($MILLION)
  • FIG. 53: STRYKER: REVENUE BY SEGMENT, 2015 (%)
  • FIG. 54: STRYKER: REVENUE BY GEOGRAPHY, 2015 (%)
Back to Top